At the IGTP TODAY
A study led by the Neuromuscular and Neuropediatric Research Group at the Germans Trias i Pujol Research Institute shows for the first time that carriers of McArdle's disease can also show symptoms.
This summer 11 students, from Badalona, Barcelona and Mollet are carrying out the practical part of their research projects for Baccalaureate through the IGTP Summer Programme in conjunction with the Organizers of the Badalona Scientific Workshops for schools
Researchers from University of Lleida-Agrotecnio, IrsiCaixa AIDS Research Institute and ICREA obtained for the first time three different anti-HIV proteins from a single transgenic rice plant and crude extracts from it averted HIV from entering in human cells in vitro. Rice components showed an enhancing effect, further helping to block HIV infectivity. Dr Julià Blanco, researcher from the Institut Germans Trias i Pujol at IrsiCaixa, where he leads the Cell Virology and Immunology group, participated in the study.
In June this year the new Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) started its normal working activities. Located at the highest point of the campus, the CMCiB is a centre promoted by the Germans Trias i Pujol Research Institute (IGTP) and dedicated to biomedical research and training. The centre is an important addition to scientific infrastructures in southern Europe and is the only one in Spain, it has been set up to become a reference in comparative medicine, bioimaging and computational models with a clear remit to promote alternative research models and methods
A paper published by the IGTP Kidney-affecting Research Group (REMAR) is in the top 100 most read cellular biology papers in Scientific Reports in 2017. The journal published around one thousand articles on cellular biology last year, making the ranking especially remarkable for this paper on which Dr Francesc Borràs is co-corresponding author. The paper is ranked at 54.
The IGTP has organized a morning with the charity Fundació Salut Alta from Badalona that got everybody sticking together! The result of the experiment was 55 balls of coloured slime and a lot of happy faces!
The IGTP-PMPPC applied health technology spin-off is one of five selected by ACCIÓ in the first edition of 'Road to Boston'. Aniling is one of five applied health technology Catalan start-ups that has started an intensive six-month tailored program to prepare for entry to Boston, one of the principal hubs in this field, to establish first contacts with key players in the sector.
Since 2007 the Immunopathology Group led by Dr Eva Martínez-Cáceres and Dr Cristian Ramo Tello at the IGTP has been working to develop a new treatment for autoimmune diseases, in this case for multiple sclerosis. To help their work in this task, Dr Martinez Cáceres has coordinated a COST project, a European network of scientists working on similar problems; the project concluded in 2017 and has now published its scientific report.
The Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP is partnering with Mind the Byte to work on the characterization and binding analysis of an immunostimulant known to trigger T-cell activation, which is crucial for the initiation and regulation of the immune response.
In a study, published in Human Mutation led by Meritxell Carrió and Eduard Serra of the IGTP in collaboration with scientists from the ICO Hereditary Cancer Program, scientists studied 8 PNF tumours to find information to help doctors predict how tumours will develop. They looked at the tissue characteristics of the tumors and then compared this to the genetic make-up of the cells within the tumour.
